We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$2.53B
(+24%)
Cap. Flow
+$1B
Cap. Flow
% of AUM
7.59%
Top 10 Holdings %
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$120M |
| 2 |
Globe Life
GL
|
+$115M |
| 3 |
MPT
Medical Properties Trust
MPT
|
+$91.5M |
| 4 |
Arch Capital
ACGL
|
+$69.2M |
| 5 |
Amazon
AMZN
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$138M |
| 2 |
GSK
GSK
|
+$98.7M |
| 3 |
Crown Holdings
CCK
|
+$92.3M |
| 4 |
American Water Works
AWK
|
+$54M |
| 5 |
SolarEdge
SEDG
|
+$45.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Financials | 15.05% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Communication Services | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
| $20.8M | 0.16% |
183,702
+17,775
| +11% | +$1.94M |
|
152
Mercado Libre
MELI
$91.9B
| $20.4M | 0.15% |
12,149
+415
| +4% | +$585K |
|
153
CVS Health
CVS
$124B
| $20.1M | 0.15% |
294,043
+37,145
| +14% | +$2.42M |
|
154
iShares TIPS Bond ETF
TIP
$14.5B
| $20M | 0.15% |
156,973
+1,343
| +0.9% | +$169K |
|
155
American Tower
AMT
$79.7B
| $19.9M | 0.15% |
88,795
+21,087
| +31% | +$4.9M |
|
|
SRCL
156
DELISTED
Stericycle Inc
SRCL
| $19.7M | 0.15% |
283,928
+52,968
| +23% | +$3.62M |
|
157
John Hancock Multifactor Mid Cap ETF
JHMM
$6.06B
| $19.5M | 0.15% |
433,331
+16,134
| +4% | +$675K |
|
158
Constellation Brands
STZ
$22.6B
| $19.5M | 0.15% |
88,894
+10,621
| +14% | +$2.09M |
|
159
Emerson Electric
EMR
$87.4B
| $19.5M | 0.15% |
242,269
+69,995
| +41% | +$5.2M |
|
160
Vanguard Morningstar Growth ETF
VUG
$230B
| $19.3M | 0.15% |
457,998
+21,678
| +5% | +$865K |
|
161
Array Technologies
ARRY
$835M
| $19M | 0.14% |
+441,200
| New | +$17.8M |
|
162
Carnival Corporation Ltd
CCL
$39.7B
| $18.8M | 0.14% |
868,840
+143,914
| +20% | +$2.56M |
|
163
iShares S&P 500 Growth ETF
IVW
$77.2B
| $18.5M | 0.14% |
289,686
-6,174
| -2% | -$374K |
|
164
Bank of America
BAC
$439B
| $18.4M | 0.14% |
608,088
+141,364
| +30% | +$3.79M |
|
165
iShares Russell 1000 Value ETF
IWD
$83.1B
| $18.2M | 0.14% |
132,824
+24,818
| +23% | +$3.18M |
|
166
TJX Companies
TJX
$178B
| $18M | 0.14% |
263,782
+12,739
| +5% | +$775K |
|
|
ORBC
167
DELISTED
ORBCOMM, Inc.
ORBC
| $17.9M | 0.14% |
2,416,562
-144,460
| -6% | -$780K |
|
168
Blackstone
BX
$106B
| $17.6M | 0.13% |
271,554
-7,403
| -3% | -$431K |
|
169
State Street Technology Select Sector SPDR ETF
XLK
$122B
| $17.6M | 0.13% |
270,302
+55,092
| +26% | +$3.36M |
|
170
AT&T
T
$162B
| $17.5M | 0.13% |
811,811
-201,412
| -20% | -$4.34M |
|
171
American Express
AXP
$232B
| $17.5M | 0.13% |
144,397
+9,955
| +7% | +$1.1M |
|
172
Workday
WDAY
$41.8B
| $17.5M | 0.13% |
72,865
+3,838
| +6% | +$862K |
|
173
iShares S&P 500 Value ETF
IVE
$49.5B
| $17.2M | 0.13% |
134,245
+10,462
| +8% | +$1.27M |
|
174
iShares Core S&P Small-Cap ETF
IJR
$112B
| $17.1M | 0.13% |
186,362
+17,209
| +10% | +$1.41M |
|
|
XYZ
175
Block Inc
XYZ
$47B
| $17M | 0.13% |
78,185
+30,497
| +64% | +$5.95M |
|
Similar funds
NAMI
Rockefeller Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.
- Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
- Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
- Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
- Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
- Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
- Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
- Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.
Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.